Pilloxa

Activities: Drug Delivery Digital Pharmaceutical

Trending Articles

  1. ICROM has acquired HOLODIAG ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services of...
  2. Lonza completes Visp microbial manufacturing facility expansion The company now hosts two 4,000L fermenters on its cGMP-compliant site, which was expanded due to the growing industry demand for biologics
  3. At CPHI Milan, TekniPlex Healthcare to Highlight New Solutions for Single-use Bioprocessing, Cell & Gene Therapies Company also will provide live demos of next-generation automatic filler-sealer for single-dose plastic vials, and showcase sustainability-minded blister packaging, as well as...
  4. PolTREG's Treg cell therapy exhibits long-term clinical remission in type 1 diabetes patients The clinical-stage biotech's lead candidate, PTG-007, has demonstrated its ability to induce clinical remission in T1D patients for up to 12 years
  5. Vetter manufactures first 100 clinical vial batches at its Austria site The CDMO has successfully completed the production of 100 liquid and lyophilised clinical batches for global clients

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Drug Delivery

Pilloxa forms strategic partnership with Bayer AB

By gaining access to both Bayer’s Scandinavian and global network through this new collaboration, Pilloxa will get the opportunity to expand the market and introduce more people to its smart pillbox
Subscribe now